Vanguard Group’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Buy |
696,764
+48,844
| +8% | +$106K | ﹤0.01% | 3625 |
|
|
2025
Q1 | $972K | Buy |
647,920
+181,643
| +39% | +$272K | ﹤0.01% | 3718 |
|
|
2024
Q4 | $2.35M | Buy |
466,277
+86,022
| +23% | +$433K | ﹤0.01% | 3516 |
|
|
2024
Q3 | $3.06M | Buy |
380,255
+18,901
| +5% | +$152K | ﹤0.01% | 3433 |
|
|
2024
Q2 | $2.08M | Buy |
361,354
+3,412
| +1% | +$19.7K | ﹤0.01% | 3543 |
|
|
2024
Q1 | $4.26M | Buy |
357,942
+20,588
| +6% | +$245K | ﹤0.01% | 3358 |
|
|
2023
Q4 | $6.31M | Buy |
337,354
+78,824
| +30% | +$1.47M | ﹤0.01% | 3192 |
|
|
2023
Q3 | $2.45M | Buy |
258,530
+6,500
| +3% | +$61.7K | ﹤0.01% | 3515 |
|
|
2023
Q2 | $3.6M | Buy |
252,030
+9,459
| +4% | +$135K | ﹤0.01% | 3456 |
|
|
2023
Q1 | $3.74M | Hold |
242,571
| – | – | ﹤0.01% | 3439 |
|
|
2022
Q4 | $3.26M | Buy |
242,571
+110
| +0% | +$1.48K | ﹤0.01% | 3482 |
|
|
2022
Q3 | $3.32M | Hold |
242,461
| – | – | ﹤0.01% | 3529 |
|
|
2022
Q2 | $2.75M | Hold |
242,461
| – | – | ﹤0.01% | 3672 |
|
|
2022
Q1 | $3.24M | Buy |
242,461
+13,306
| +6% | +$178K | ﹤0.01% | 3736 |
|
|
2021
Q4 | $4.03M | Sell |
229,155
-329
| -0.1% | -$5.78K | ﹤0.01% | 3728 |
|
|
2021
Q3 | $7.29M | Buy |
229,484
+31
| +0% | +$984 | ﹤0.01% | 3427 |
|
|
2021
Q2 | $19.6M | Buy |
229,453
+82,452
| +56% | +$7.06M | ﹤0.01% | 2859 |
|
|
2021
Q1 | $4.1M | Buy |
+147,001
| New | +$4.1M | ﹤0.01% | 3629 |
|